163 related articles for article (PubMed ID: 20702526)
1. Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction.
Zeller M; Danchin N; Simon D; Vahanian A; Lorgis L; Cottin Y; Berland J; Gueret P; Wyart P; Deturck R; Tabone X; Machecourt J; Leclercq F; Drouet E; Mulak G; Bataille V; Cambou JP; Ferrieres J; Simon T;
J Clin Endocrinol Metab; 2010 Nov; 95(11):4993-5002. PubMed ID: 20702526
[TBL] [Abstract][Full Text] [Related]
2. Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry.
Danchin N; Charpentier G; Ledru F; Vaur L; Guéret P; Hanania G; Blanchard D; Lablanche JM; Genès N; Cambou JP
Diabetes Metab Res Rev; 2005; 21(2):143-9. PubMed ID: 15386810
[TBL] [Abstract][Full Text] [Related]
3. Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure.
Andersson C; Gislason GH; Jørgensen CH; Hansen PR; Vaag A; Sørensen R; Mérie C; Olesen JB; Weeke P; Schmiegelow M; Norgaard ML; Køber L; Torp-Pedersen C
Diabetes Res Clin Pract; 2011 Oct; 94(1):119-25. PubMed ID: 21831467
[TBL] [Abstract][Full Text] [Related]
4. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
[TBL] [Abstract][Full Text] [Related]
5. Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study.
Horsdal HT; Johnsen SP; Søndergaard F; Jacobsen J; Thomsen RW; Schmitz O; Sørensen HT; Rungby J
Diabetes Metab Res Rev; 2009 Sep; 25(6):515-22. PubMed ID: 19459168
[TBL] [Abstract][Full Text] [Related]
6. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
Horsdal HT; Mehnert F; Rungby J; Johnsen SP
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
[TBL] [Abstract][Full Text] [Related]
7. Mortality risk among sulfonylureas: a systematic review and network meta-analysis.
Simpson SH; Lee J; Choi S; Vandermeer B; Abdelmoneim AS; Featherstone TR
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):43-51. PubMed ID: 25466239
[TBL] [Abstract][Full Text] [Related]
8. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.
Schramm TK; Gislason GH; Vaag A; Rasmussen JN; Folke F; Hansen ML; Fosbøl EL; Køber L; Norgaard ML; Madsen M; Hansen PR; Torp-Pedersen C
Eur Heart J; 2011 Aug; 32(15):1900-8. PubMed ID: 21471135
[TBL] [Abstract][Full Text] [Related]
9. Impairment of myocardial protection in type 2 diabetic patients.
Lee TM; Chou TF
J Clin Endocrinol Metab; 2003 Feb; 88(2):531-7. PubMed ID: 12574175
[TBL] [Abstract][Full Text] [Related]
10. Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction.
Halkin A; Roth A; Jonas M; Behar S
J Thromb Thrombolysis; 2001 Oct; 12(2):177-84. PubMed ID: 11729370
[TBL] [Abstract][Full Text] [Related]
11. Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population.
Juurlink DN; Gomes T; Shah BR; Mamdani MM
Diabet Med; 2012 Dec; 29(12):1524-8. PubMed ID: 22913620
[TBL] [Abstract][Full Text] [Related]
12. Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome).
Puymirat E; Taldir G; Aissaoui N; Lemesle G; Lorgis L; Cuisset T; Bourlard P; Maillier B; Ducrocq G; Ferrieres J; Simon T; Danchin N
JACC Cardiovasc Interv; 2012 Sep; 5(9):893-902. PubMed ID: 22995875
[TBL] [Abstract][Full Text] [Related]
13. Coronary heart disease outcomes in patients receiving antidiabetic agents.
McAfee AT; Koro C; Landon J; Ziyadeh N; Walker AM
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
[TBL] [Abstract][Full Text] [Related]
14. Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study.
Khalangot M; Tronko M; Kravchenko V; Kovtun V
Diabetes Res Clin Pract; 2009 Dec; 86(3):247-53. PubMed ID: 19796836
[TBL] [Abstract][Full Text] [Related]
15. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.
Garratt KN; Brady PA; Hassinger NL; Grill DE; Terzic A; Holmes DR
J Am Coll Cardiol; 1999 Jan; 33(1):119-24. PubMed ID: 9935017
[TBL] [Abstract][Full Text] [Related]
16. Comparing kidney outcomes in type 2 diabetes treated with different sulphonylureas in real-life clinical practice.
Lee YH; Lee CJ; Lee HS; Choe EY; Lee BW; Ahn CW; Cha BS; Lee HC; Balkau B; Kang ES
Diabetes Metab; 2015 Jun; 41(3):208-15. PubMed ID: 25687901
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of conventional sulfonylureas and glimepiride.
Geisen K; Végh A; Krause E; Papp JG
Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987
[TBL] [Abstract][Full Text] [Related]
18. Sulfonylureas and mortality in diabetic patients after myocardial infarction.
Brady PA; Al-Suwaidi J; Kopecky SL; Terzic A
Circulation; 1998 Feb; 97(7):709-10. PubMed ID: 9495313
[No Abstract] [Full Text] [Related]
19. [Risk and benefit of sulfonylureas--their role in view of new treatment options for type 2 diabetes].
Rustenbeck I
Med Monatsschr Pharm; 2016 Feb; 39(2):65-72; quiz 73-4. PubMed ID: 26983335
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study.
Horsdal HT; Søndergaard F; Johnsen SP; Rungby J
Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):331-7. PubMed ID: 21442682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
